Dunlap Ryan 4
4 · Galena Biopharma, Inc. · Filed Jan 31, 2013
Insider Transaction Report
Form 4
Dunlap Ryan
Principal Accounting Officer
Transactions
- Other
Common Stock, par value $0.0001
2012-12-31$1.30/sh+1,246$1,620→ 1,246 total - Award
Stock Option (right to buy)
2013-01-29+40,000→ 40,000 totalExercise: $1.71Exp: 2023-01-29→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]Granted Pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
- [F3]Option vests in quarterly installments over four years beginning on the first quarterly anniversary of January 29, 2013, as long as Reporting Person remains continuously employed by the Issuer through such quarterly anniversary dates.